Ajax Health, the medical device portfolio management company newly formed by KKR and Aisling Capital, led a $45 million round for Advanced Cardiac Therapeutics and the next-generation ablation catheter it’s developing. Earlier today the private equity giants launched tapped Spirox chairman & CEO Duke Rohlen to lead Ajax Health. Rohlen, the former president of FoxHollow Technologies and the founder & former chief executive of […]
Advanced Catheter Therapies
Advanced Catheter Therapies said today that it inked a worldwide license deal with Toray Industries for the manufacture and sale of ACT’s Occlusion Perfusion Catheter for peripheral vascular stenosis and restenosis. Chattanooga, Tenn.-based ACT said it’s been manufacturing the OPC device for about a year for clinical trials and a test release. “Our 1st-in-human clinical trials have been very […]
Advanced Catheter Therapies said today it won a 2nd FDA 510(k) for its Occlusion Perfusion catheter, covering a new range of sizes for the device. The OPC is a multi-lumen balloon catheter designed to occlude vessels for the local delivery of therapeutic agents, the Chattanooga, Tenn.-based company said. “ACT is very excited about this second […]
August 22, 2014 by Arezu Sarvestani
Tennessee-based medical device maker Advanced Catheter Therapies pushed the cap on its Series B funding round after generating more interest that it expected.
The company is now looking to raise $4.5 million where it had previously sought $3 million in support of its catheter-based endovascular drug delivery technology.